Clinical Trial Update: Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating PET/MRI using a somatostatin analog tracer as a novel approach to detect pathology in high-risk TB-exposed contacts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Pulmonary

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Tuberculosis, Pulmonary | Phase 1 | Status: UNKNOWN